EP3582801A4 - Composés excipients destinés au traitement de protéines - Google Patents

Composés excipients destinés au traitement de protéines Download PDF

Info

Publication number
EP3582801A4
EP3582801A4 EP18754459.8A EP18754459A EP3582801A4 EP 3582801 A4 EP3582801 A4 EP 3582801A4 EP 18754459 A EP18754459 A EP 18754459A EP 3582801 A4 EP3582801 A4 EP 3582801A4
Authority
EP
European Patent Office
Prior art keywords
protein processing
excipient compounds
excipient
compounds
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18754459.8A
Other languages
German (de)
English (en)
Other versions
EP3582801A1 (fr
Inventor
David S. Soane
Philip Wuthrich
Robert P. Mahoney
Mark Moody
Daniel G. GREENE
Neil L. Schauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Comera Life Sciences Inc
Original Assignee
Reform Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reform Biologics Inc filed Critical Reform Biologics Inc
Publication of EP3582801A1 publication Critical patent/EP3582801A1/fr
Publication of EP3582801A4 publication Critical patent/EP3582801A4/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Water Supply & Treatment (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP18754459.8A 2017-02-16 2018-02-14 Composés excipients destinés au traitement de protéines Pending EP3582801A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762459893P 2017-02-16 2017-02-16
PCT/US2018/018123 WO2018152165A1 (fr) 2017-02-16 2018-02-14 Composés excipients destinés au traitement de protéines

Publications (2)

Publication Number Publication Date
EP3582801A1 EP3582801A1 (fr) 2019-12-25
EP3582801A4 true EP3582801A4 (fr) 2020-12-23

Family

ID=63170449

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18754459.8A Pending EP3582801A4 (fr) 2017-02-16 2018-02-14 Composés excipients destinés au traitement de protéines

Country Status (5)

Country Link
EP (1) EP3582801A4 (fr)
JP (1) JP2020507593A (fr)
KR (1) KR102572453B1 (fr)
CA (1) CA3053909A1 (fr)
WO (1) WO2018152165A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015196091A1 (fr) 2014-06-20 2015-12-23 Reform Biologics, Llc Composés excipient réduisant la viscosité pour formulations à base de protéines
US10478498B2 (en) 2014-06-20 2019-11-19 Reform Biologics, Llc Excipient compounds for biopolymer formulations
CN112040931A (zh) * 2018-03-07 2020-12-04 改进生物制品有限责任公司 用于蛋白质制剂的赋形剂化合物
KR20210096633A (ko) * 2018-11-29 2021-08-05 리폼 바이오로직스, 엘엘씨 단백질 처리를 위한 부형제 화합물
TW202043253A (zh) * 2019-01-28 2020-12-01 美商安進公司 藉由將藥物物質和藥物產品過程整體化的生物製劑製造之連續製造過程
US20220348608A1 (en) * 2019-10-04 2022-11-03 Merck Patent Gmbh Purification of proteins and viral inactivation
CN113621360A (zh) * 2020-05-06 2021-11-09 中国石油化工股份有限公司 一种稠油降粘剂及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5710311B2 (ja) * 2011-02-18 2015-04-30 株式会社日立製作所 添加培地の添加制御方法、及び当該方法を用いた細胞培養装置
EP2771033A4 (fr) * 2011-10-28 2016-02-17 Integritybio Inc Formulations protéiques contenant des acides aminés
EP2682168A1 (fr) * 2012-07-02 2014-01-08 Millipore Corporation Dispositif de tirage et métier à filer
RU2675824C2 (ru) * 2013-09-11 2018-12-25 Игл Байолоджикс, Инк. Жидкие белковые составы, содержащие ионные жидкости
WO2015196091A1 (fr) * 2014-06-20 2015-12-23 Reform Biologics, Llc Composés excipient réduisant la viscosité pour formulations à base de protéines
KR102497368B1 (ko) * 2014-10-01 2023-02-10 이글 바이올로직스 인코포레이티드 점도-저하제를 함유하는 폴리삭카라이드 및 핵산 제형

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
JP2020507593A (ja) 2020-03-12
KR20190117631A (ko) 2019-10-16
KR102572453B1 (ko) 2023-08-29
EP3582801A1 (fr) 2019-12-25
CA3053909A1 (fr) 2018-08-23
WO2018152165A1 (fr) 2018-08-23

Similar Documents

Publication Publication Date Title
EP3658522A4 (fr) Composés immunomodulateurs
EP3455218A4 (fr) Dégronimères de type glutarimide liés au carbone c3 pour la dégradation de protéines cibles
EP3454856A4 (fr) Dégronimères hétérocycliques pour la dégradation de protéines cibles
EP3474845A4 (fr) Composés immunomodulateurs
EP3160484A4 (fr) Composés excipient réduisant la viscosité pour formulations à base de protéines
EP3567537A4 (fr) Système de traitement de commande
EP3582801A4 (fr) Composés excipients destinés au traitement de protéines
TWI799435B (zh) 製備化合物之製程
EP3386530A4 (fr) Peptides pour thérapie rénale
EP3383418A4 (fr) Peptides slc45a2 pour l'immunothérapie
EP3585801A4 (fr) Méthodes de criblage d'infections
EP3369741A4 (fr) Nouveau peptide
EP3886909A4 (fr) Composés d'excipients destinés au traitement de protéines
EP3467106A4 (fr) Composé peptidique
EP3496662A4 (fr) Protéine dérivée de la soie pour le traitement d'une inflammation
EP3513821A4 (fr) Matériau de purification du sang
EP3347996A4 (fr) Système de traitement analogique pour mimo massif
EP3325587A4 (fr) Système de traitement de matière organique
EP3265109A4 (fr) Méthodes de préparation de peptides pertinents sur le plan pharmaceutique
EP3463414A4 (fr) Interfaces de protéines
EP3761962A4 (fr) Composés excipients pour formulations à base de protéines
EP3365021A4 (fr) Composés excipients pour des formulations de biopolymères
EP3403128A4 (fr) Placement de balayage à motif simultané pendant le traitement d'un échantillon
EP3595615A4 (fr) Traitement de la gingivite
EP3441887A4 (fr) Système de traduction

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190905

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0038160000

Ipc: C07K0001340000

A4 Supplementary search report drawn up and despatched

Effective date: 20201120

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 16/00 20060101ALI20201116BHEP

Ipc: A61K 39/395 20060101ALI20201116BHEP

Ipc: C07K 1/22 20060101ALI20201116BHEP

Ipc: A61K 38/16 20060101ALI20201116BHEP

Ipc: C07K 1/34 20060101AFI20201116BHEP

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: REFORM BIOLOGICS, INC.

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: COMERA LIFE SCIENCES, INC.

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230516

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230912